DEFINITIVE PROXY STATEMENT

Company

PharmaCyte Biotech, Inc.

Filed

March 9, 2026

Period of Report

March 30, 2026

Accession Number

0001683168-26-001593

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →